Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renqing Changjue is a prominent traditional Tibetan medicine (TTM) classified as a "precious pill" (Rinchen Tselwa). It is a complex, multi-ingredient formulation comprising over 140 components, including processed minerals, metals (such as gold, silver, and copper), and numerous medicinal herbs like saffron and sandalwood. A key component is "Tsothel," a specially processed mercury sulfide preparation. Traditionally, it is used for a wide spectrum of ailments including gastrointestinal disorders, chronic inflammation, poisoning, and as a general health tonic. Modern clinical research, including studies registered in the Chinese Clinical Trial Registry, has begun to investigate its potential in treating metabolic disorders such as type 2 diabetes mellitus, specifically focusing on its immunomodulatory effects and ability to regulate inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Renqing Changjue.